
Denis Marchand
R&D & Innovation Manager - Biopharmaceuticals - Bioproduction
POLEPHARMA
About me
In topic of Bioproduction , Biopharmaceuticals
Denis Marchand, R&D & Innovation Manager for Biopharmaceuticals & Bioproduction at the Polepharma cluster, which brings together over 470 key players in the pharmaceutical, biopharmaceutical, and drug development industries.
With significant experience in this field, my role is to connect industry players to strengthen innovation and, in particular, accelerate the bioproduction of biopharmaceuticals.
If your are here, I believe if that our discussions could be productive in sharing our respective expertise and, perhaps, exploring opportunities for collaboration.
I am confident that this connection will benefit both our networks.
Feel free to reach out to discuss further.Looking forward to our exchange. Contact me !
Attendee Access type
Attendee EARLY ACCESS
Country
France
Organization Type
Association/Government
Business Activity
Analytical ServicesAPI ProducerBiopharmaceuticalChemical DevelopmentCleanroom TechnologyContract ManufacturerContract Research OrganisationCustom Manufacturing/ Custom SynthesisExcipients ManufacturerFine Chemicals CompanyIntermediates ManufacturerLaboratory, Analytical, Biotechnology EquipmentLaboratory ServicesPackaging & Drug DeliveryRegulatory AffairsSupply ChainTechnology
Markets Active In
Europe - EU countries
Interested In:
In which geographical areas you plan to expand
Europe - EU countries
About me (Individual)
Department
Research & Development
Job Function
Manager with staff
Purchasing Responsibility
I have no purchasing responsibility
Geographical areas you plan to expand to:
Europe - EU countries
Offering/Interested In
Interested in: Business Type
Analytical ServicesBiopharmaceuticalLaboratory,Analytical,Biotechnology EquipmentTechnology
Interested in: Company Type
Academic/ResearchAssociation/GovernmentContract ServiceEngineeringManufacturer/Innovator
Interested In: Company Certification
GMPISONone
Interested In: Product Certification
CEFDANone
Interested In
Interested In: Products & Service Category
BiopharmaceuticalsContract Services - Analytical & Lab ServicesContract Services - Bio ServicesContract Services - Contract ServicesContract Services - Pre-Clinical Trials, Clinical Trials Stages 1-4, CRO, Clinical DaCustom ManufacturingLaboratory and Analytical Equipment
Interested In: Biopharmaceuticals
Academia and Research CentresAnalytical ChemistryAnalytical MethodsAntibody Drug Conjugates (ADCs)Bio ClustersBio Process TechnologiesBiomanufacturingBiopharmaceuticals (general category)Bioreactors & FermentationCell & Gene therapyCHO and cell linesCMCContinuous BioprocessingCritical quality attributesDownstreamExpression platformsGenomics & ProteomicsImmunologyMolecular BiologyMonoclonal AntibodiesPlatform TechnologiesProcess ValidationProtein ChemistryRegenerative MedicineTech transfer and Scale upTechnology and SoftwareUpstreamViral Clearance
Interested In: Contract Services
Academia and Research CentresAnalytical DevelopmentAnalytical MethodsBio Analytical ServicesBioinformaticsBlendingCell BiologyCell-culture DevelopmentChromatographyEquipment and suppliesFormulation DevelopmentImmunologyMethod DevelopmentMethod ValidationPharmacologyProcess OptimisationProcess ValidationProduct CharacterizationProject ManagementProtein ChemistryQuality Control TestingStability Testing
Interested In: Custom Manufacturing
Purification and Separation Techniques
Interested In: Laboratory and Analytical Equipment
Analytical ConsumablesAnalytical EquipmentBiocomputingCleaning equipmentCleanroom technlogyHygiene testingInstrumental analysis
Content
Company
POLEPHARMA
Social media
Contact details
Is member of

POLEPHARMA
Exhibitors
POLEPHARMA
Exhibitors
POLEPHARMA
Exhibitorsis attending
Optimization Bispecific Antibodies Downstream Processing: Seeking Homodimer Removal
BioProduction Content - 3C49
CDMO 2.0: Uncovering the Missing Element in Next-Generation Pharma Partnerships
Tuesday, October 24, 2023 12:15 PM to 12:35 PM
CPHI Content Hub - CC4.3
Peter Andersen · Grupo Centroflora
Cell & Gene Therapies: Addressing Manufacturing Challenges to Accelerate Innovation
Wednesday, October 25, 2023 9:15 AM to 9:35 AM
CPHI Content Hub - CC4.3
Fast, Insight Driven Process Development with Hybrid Modeling and Knowledge Transfer
Tuesday, October 24, 2023 9:00 AM to 9:30 AM
BioProduction Content - 3C49
Reactor simulations made accurate, fast and easy
BioProduction Content - 3C49